Bitcoin Closed Q3 With 11% Price Loss. #Bitcoin ended the third quarter of 2023 with a price decline of 11.

01 Oct 2023, 12:30
Bitcoin Closed Q3 With 11% Price Loss šŸ“‰ #Bitcoin ended the third quarter of 2023 with a price decline of 11.4% primarily driven by a significant downward price movement in August. Meanwhile, #BTC closed September with a 4% price increase.

Same news in other sources

9
Humanode
HumanodeHMND #1377
Twitter
04 Oct 2023, 14:02
āš”ļø @blackbird_xyz , a loyalty, memberships, and payments platform, has raised $24M in a Series A round led by @a16zcrypto . Other investors include @usv , @variantfund , Amex Ventures, @QEDInvestors , and @ShineCapitalNYC .
ļø @blackbird_xyz , a loyalty, memberships, and payments platform, has raised $24M in a Series A round led by @a16zcrypto .
āš”ļø @blackbird_xyz , a loyalty, memberships, and payments platform, has raised $24M in a Series A round led by @a16zcrypto . Other investors include @usv , @variantfund , Amex Ventures, @QEDInvestors , and @ShineCapitalNYC .
Humanode
HumanodeHMND #1377
Twitter
04 Oct 2023, 13:49
TVL Performance on Multiple Networks in Q3 2023 The combined total value locked on all blockchains declined in the third quarter of 2023.
TVL Performance on Multiple Networks in Q3 2023.
TVL Performance on Multiple Networks in Q3 2023 The combined total value locked on all blockchains declined in the third quarter of 2023.
Humanode
HumanodeHMND #1377
Twitter
03 Oct 2023, 16:42
Top Gainers in Q3 2023 šŸ“ˆ
Top Gainers in Q3 2023.
Top Gainers in Q3 2023 šŸ“ˆ
Humanode
HumanodeHMND #1377
Twitter
03 Oct 2023, 10:16
Top 10 Biggest Fundraising Rounds in Q3 2023 Discover the biggest fundraising rounds in Q3 2023 with participation from Tier-1 #crypto VC funds.
Top 10 Biggest Fundraising Rounds in Q3 2023.
Top 10 Biggest Fundraising Rounds in Q3 2023 Discover the biggest fundraising rounds in Q3 2023 with participation from Tier-1 #crypto VC funds.
Humanode
HumanodeHMND #1377
Twitter
02 Oct 2023, 13:50
Trading Volume on Decentralised Exchanges Down 33.6% in Q3 2023 Decentralised exchange trading volume in Q3 was $133.3B - a decrease of 33.6% compared to Q2. Maverick Protocol $MAV became the only DEX to show trading volume growth among the top 10 market leaders. SushiSwap $SUSHI showed the worst trading volume dynamics with an 83.3% quarterly decline.
Trading Volume on Decentralised Exchanges Down 33. 6% in Q3 2023. Decentralised exchange trading volume in Q3 was $133.
Trading Volume on Decentralised Exchanges Down 33.6% in Q3 2023 Decentralised exchange trading volume in Q3 was $133.3B - a decrease of 33.6% compared to Q2. Maverick Protocol $MAV became the only DEX to show trading volume growth among the top 10 market leaders. SushiSwap $SUSHI showed the worst trading volume dynamics with an 83.3% quarterly decline.
Humanode
HumanodeHMND #1377
Twitter
02 Oct 2023, 13:48
Crypto Startups Raised $560M in September šŸ”„ #Crypto startups raised a total of $560M in investment in September, up 60.5% from August. #Blockchain Services raised the largest amount of funding - $142M, followed by #GameFi ($119M) and Blockchain Infrastructure ($71M).
Crypto Startups Raised $560M in September. #Crypto startups raised a total of $560M in investment in September, up 60.
Crypto Startups Raised $560M in September šŸ”„ #Crypto startups raised a total of $560M in investment in September, up 60.5% from August. #Blockchain Services raised the largest amount of funding - $142M, followed by #GameFi ($119M) and Blockchain Infrastructure ($71M).
Triall
TriallTRL #2216
Telegram
02 Oct 2023, 11:23
Triall Insights šŸ” 70% of research site staff believe that conducting clinical trials has become much more difficult over the past 5 years. The most commonly reported issues include staffing challenges, study budgets, and protocol complexity. Source: csdd.tufts.edu/impact-reports āš”ļø Trade $TRL at bit.ly/tradeTRL šŸ—£ Help us spread the news on Twitter: #blockchainforhealth #TRL
Triall Insights.
Triall Insights šŸ” 70% of research site staff believe that conducting clinical trials has become much more difficult over the past 5 years. The most commonly reported issues include staffing challenges, study budgets, and protocol complexity. Source: csdd.tufts.edu/impact-reports āš”ļø Trade $TRL at bit.ly/tradeTRL šŸ—£ Help us spread the news on Twitter: https://x.com/triallofficial/status/1708804862845022296?s=20 #blockchainforhealth #TRL
Triall
TriallTRL #2216
Telegram
02 Oct 2023, 11:23
Triall Insights šŸ” 70% of research site staff believe that conducting clinical trials has become much more difficult over the past 5 years. The most commonly reported issues include staffing challenges, study budgets, and protocol complexity. Source: csdd.tufts.edu/impact-reports āš”ļø Trade $TRL at bit.ly/tradeTRL šŸ—£ Help us spread the news on Twitter: #blockchainforhealth #TRL
Triall Insights.
Triall Insights šŸ” 70% of research site staff believe that conducting clinical trials has become much more difficult over the past 5 years. The most commonly reported issues include staffing challenges, study budgets, and protocol complexity. Source: csdd.tufts.edu/impact-reports āš”ļø Trade $TRL at bit.ly/tradeTRL šŸ—£ Help us spread the news on Twitter: https://x.com/triallofficial/status/1708804862845022296?s=20 #blockchainforhealth #TRL
Humanode
HumanodeHMND #1377
Twitter
02 Oct 2023, 11:09
Top Gainers in September 2023 šŸ”„
Top Gainers in September 2023.
Top Gainers in September 2023 šŸ”„